Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features.

Xin G, Shi W, Xu LX, Su Y, Yan LJ, Li KS.

J Nephrol. 2013 Jul-Aug;26(4):683-90. doi: 10.5301/jn.5000218. Epub 2012 Oct 4.

PMID:
23042433
2.

Expression profile of BAFF in peripheral blood from patients of IgA nephropathy: Correlation with clinical features and Streptococcus pyogenes infection.

Zheng N, Fan J, Wang B, Wang D, Feng P, Yang Q, Yu X.

Mol Med Rep. 2017 Apr;15(4):1925-1935. doi: 10.3892/mmr.2017.6190. Epub 2017 Feb 10.

PMID:
28260100
3.

TLR9 and BAFF: their expression in patients with IgA nephropathy.

Li W, Peng X, Liu Y, Liu H, Liu F, He L, Liu Y, Zhang F, Guo C, Chen G, Zhang L, Dong Z, Peng Y.

Mol Med Rep. 2014 Sep;10(3):1469-74. doi: 10.3892/mmr.2014.2359. Epub 2014 Jul 1.

PMID:
24993857
4.

[Therapeutic effects and prognostic factors in tonsillectomy patients with IgA nephropathy].

Goto T, Bandoh N, Yoshizaki T, Takahara M, Nonaka S, Harabuchi Y.

Nihon Jibiinkoka Gakkai Kaiho. 2007 Feb;110(2):53-9. Japanese.

PMID:
17373325
5.

Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.

Liu LL, Jiang Y, Wang LN, Liu N.

Clin Exp Immunol. 2012 Aug;169(2):148-55. doi: 10.1111/j.1365-2249.2012.04604.x.

6.

Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy.

Goto T, Bandoh N, Yoshizaki T, Nozawa H, Takahara M, Ueda S, Hayashi T, Harabuchi Y.

Clin Immunol. 2008 Mar;126(3):260-9. doi: 10.1016/j.clim.2007.11.003. Epub 2008 Jan 14.

PMID:
18249037
7.

Serum BAFF and APRIL might be associated with disease activity and kidney damage in patients with anti-glomerular basement membrane disease.

Xin G, Cui Z, Su Y, Xu LX, Zhao MH, Li KS.

Nephrology (Carlton). 2013 Mar;18(3):209-14. doi: 10.1111/nep.12032.

PMID:
23317407
8.

Does circulating erythropoietin reflect progression of IgA nephropathy? Comparison with urinary N-acetyl-beta-D-glucosaminidase.

Machiguchi T, Yoshida H, Yonemoto S, Minakata T, Nomura K, Muso E, Tamura T, Sasayama S.

Nephrol Dial Transplant. 1999 Mar;14(3):635-40.

PMID:
10193812
9.

Synthetic Double-Stranded RNA Poly(I:C) Aggravates IgA Nephropathy by Triggering IgA Class Switching Recombination through the TLR3-BAFF Axis.

He L, Peng X, Wang J, Tang C, Zhou X, Liu H, Liu F, Sun L, Peng Y.

Am J Nephrol. 2015;42(3):185-97. doi: 10.1159/000440819. Epub 2015 Sep 30.

PMID:
26417991
10.

Insulin-like growth factor binding protein-1 levels are increased in patients with IgA nephropathy.

Tokunaga K, Uto H, Takami Y, Mera K, Nishida C, Yoshimine Y, Fukumoto M, Oku M, Sogabe A, Nosaki T, Moriuchi A, Oketani M, Ido A, Tsubouchi H.

Biochem Biophys Res Commun. 2010 Aug 20;399(2):144-9. doi: 10.1016/j.bbrc.2010.07.032. Epub 2010 Jul 15.

PMID:
20637724
11.

Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.

Myllymäki J, Honkanen T, Syrjänen J, Helin H, Rantala I, Pasternack A, Mustonen J.

Nephrol Dial Transplant. 2005 Jan;20(1):89-95. Epub 2004 Nov 30.

PMID:
15572382
12.

Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.

Sonoda Y, Gohda T, Suzuki Y, Omote K, Ishizaka M, Matsuoka J, Tomino Y.

PLoS One. 2015 Apr 10;10(4):e0122212. doi: 10.1371/journal.pone.0122212. eCollection 2015.

13.

The level of serum secretory IgA of patients with IgA nephropathy is elevated and associated with pathological phenotypes.

Zhang JJ, Xu LX, Liu G, Zhao MH, Wang HY.

Nephrol Dial Transplant. 2008 Jan;23(1):207-12. Epub 2007 Oct 15.

PMID:
17938148
14.

Correlation of serum levels of complement C4a desArg with pathologically estimated severity of glomerular lesions and mesangial hypercellularity scores in patients with IgA nephropathy.

Sogabe A, Uto H, Kanmura S, Nosaki T, Oyamada M, Tokunaga K, Nishida C, Fukumoto M, Oku M, Nishimoto K, Takenouchi S, Ido A, Shimada Y, Tsubouchi H.

Int J Mol Med. 2013 Aug;32(2):307-14. doi: 10.3892/ijmm.2013.1390. Epub 2013 May 24.

PMID:
23708385
15.

Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.

Matsushita T, Fujimoto M, Hasegawa M, Tanaka C, Kumada S, Ogawa F, Takehara K, Sato S.

J Rheumatol. 2007 Oct;34(10):2056-62. Epub 2007 Sep 15.

PMID:
17896803
16.

Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.

Lundberg S, Lundahl J, Gunnarsson I, Sundelin B, Jacobson SH.

Nephrol Dial Transplant. 2012 May;27(5):1916-23. doi: 10.1093/ndt/gfr554. Epub 2011 Sep 22.

PMID:
21940483
17.

Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.

Krystufková O, Vallerskog T, Helmers SB, Mann H, Putová I, Belácek J, Malmström V, Trollmo C, Vencovsky J, Lundberg IE.

Ann Rheum Dis. 2009 Jun;68(6):836-43. doi: 10.1136/ard.2008.091405. Epub 2008 Jul 15.

PMID:
18628284
18.

Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.

Xie YX, He LY, Chen X, Peng XF, Ye MY, Zhao YJ, Yan WZ, Liu C, Shao J, Peng YM.

Int Urol Nephrol. 2016 Nov;48(11):1855-1861. Epub 2016 Jul 27.

PMID:
27465795
19.

Elevated serum BAFF levels in patients with localized scleroderma in contrast to other organ-specific autoimmune diseases.

Matsushita T, Hasegawa M, Matsushita Y, Echigo T, Wayaku T, Horikawa M, Ogawa F, Takehara K, Sato S.

Exp Dermatol. 2007 Feb;16(2):87-93.

PMID:
17222220
20.

[Clinical and pathological features of IgA nephropathy in west Guangdong province].

Chen WL, Lin HP, Liu HF.

Nan Fang Yi Ke Da Xue Xue Bao. 2010 May;30(5):1150-1. Chinese.

Supplemental Content

Support Center